Your browser doesn't support javascript.
loading
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study.
Deuschl, Cornelius; Moenninghoff, Christoph; Goericke, Sophia; Kirchner, Julian; Köppen, Susanne; Binse, Ina; Poeppel, Thorsten D; Quick, Harald H; Forsting, Michael; Umutlu, Lale; Herrmann, Ken; Hense, Joerg; Schlamann, Marc.
Afiliación
  • Deuschl C; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122, Essen, Germany. cornelius.deuschl@uk-essen.de.
  • Moenninghoff C; Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Duisburg, Germany. cornelius.deuschl@uk-essen.de.
  • Goericke S; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
  • Kirchner J; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
  • Köppen S; Institute of Diagnostic and Interventional Radiology, University Hospital Duesseldorf, Duesseldorf, Germany.
  • Binse I; Department of Neurology, University Hospital Essen, Essen, Germany.
  • Poeppel TD; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Quick HH; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Forsting M; Erwin L. Hahn Institute for Magnetic Resonance Imaging, University of Duisburg-Essen, Duisburg, Germany.
  • Umutlu L; High Field and Hybrid MR Imaging, University Hospital Essen, Essen, Germany.
  • Herrmann K; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
  • Hense J; Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Hufelandstrasse 55, D-45122, Essen, Germany.
  • Schlamann M; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
Eur J Nucl Med Mol Imaging ; 44(8): 1285-1295, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28258444
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Imagen por Resonancia Magnética / Glioblastoma / Imagen Multimodal / Bevacizumab / Metionina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Imagen por Resonancia Magnética / Glioblastoma / Imagen Multimodal / Bevacizumab / Metionina Tipo de estudio: Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2017 Tipo del documento: Article País de afiliación: Alemania